BridgeMD
New treatment option for Cerebral Palsy
Official title Effects of Proprioceptive Neuromuscular Facilitation and Task-Oriented Training on Upper Extremity Function in Children With Spastic Diplegic Cerebral Palsy
ClinicalTrials.gov ID: NCT07694804
What this study is testing
- What it's testing
- Children with spastic diplegic cerebral palsy often experience upper extremity impairments, including reduced coordination, muscle control, and functional hand use, which limit independence in daily activities. Proprioceptive Neuromuscular Facilitation (PNF) and Task-Oriented Training (TOT) are commonly used rehabilitation approaches to improve motor function; however, evidence comparing their individual and combined effects on upper extremity function remains limited.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 12
You may be able to join if
- Children aged 6 to 12 years.
- Clinical diagnosis of spastic diplegic cerebral palsy.
- Gross Motor Function Classification System (GMFCS) Levels I-III.
- Ability to understand and follow simple verbal instructions.
- Medically stable and able to participate in physiotherapy sessions.
You likely can't join if
- Orthopedic surgery involving the upper or lower extremities within the previous 6 months.
- Botulinum toxin injections administered within the previous 6 months.
- Severe visual, hearing, or cognitive impairments that would interfere with assessment or treatment.
- Uncontrolled epilepsy or other unstable neurological or medical conditions.
- Fixed upper extremity contractures or musculoskeletal deformities preventing participation in the intervention.
- Participation in another structured upper extremity rehabilitation program during the study period.
See the full eligibility criteria
- Children aged 6 to 12 years.
- Clinical diagnosis of spastic diplegic cerebral palsy.
- Gross Motor Function Classification System (GMFCS) Levels I-III.
- Ability to understand and follow simple verbal instructions.
- Medically stable and able to participate in physiotherapy sessions.
- Parent or legal guardian willing to provide written informed consent.
- Orthopedic surgery involving the upper or lower extremities within the previous 6 months.
- Botulinum toxin injections administered within the previous 6 months.
- Severe visual, hearing, or cognitive impairments that would interfere with assessment or treatment.
- Uncontrolled epilepsy or other unstable neurological or medical conditions.
- Fixed upper extremity contractures or musculoskeletal deformities preventing participation in the intervention.
- Participation in another structured upper extremity rehabilitation program during the study period.
- Failure to obtain informed consent from a parent or legal guardian.
The study team makes the final eligibility decision.
Where it's taking place
- Mansehra, KPK, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mansehra, KPK, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.